William A. Hawkins

Bill is retired Chairman and CEO of Medtronic, one of the world’s largest and most innovative medical technology companies. He joined Medtronic in 2002, holding several leadership positions prior to serving as Chairman and CEO. Most recently, Bill was President and CEO of Immucor, a provider of transfusion and transplantation diagnostic products worldwide. Prior to Medtronic, he served as President and CEO of Novoste Corp. (Nasdaq: NOVT) and held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corp. and Eli Lilly & Co. He began his medical technology career with Carolina Medical Electronics in 1977. Bill is active on public, private and not-for-profit boards including Halyard Health (NYSE: HYH), KeraNetics and the Duke University Health System. He also serves as a member of the Advisory Boards at Arboretum Ventures, Radius Ventures, LLC, HealthQuest Ventures, Accuitive Medical Ventures, A*STAR SERC Cluster Advisory Board in Singapore and the Biomedical Sciences International Advisory Council, Singapore (“BMS IAC”). He received his BS in Electrical and Biomedical Engineering from Duke, where he also conducted medical research in pathology. He then went on to earn an MBA from the Darden School of Business, University of Virginia.